Toll Free: 1-888-928-9744
Published: Dec, 2014 | Pages:
44 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Onyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Onyx Pharmaceuticals, Inc. - Product Pipeline Review - 2014', provides an overview of the Onyx Pharmaceuticals, Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Onyx Pharmaceuticals, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Onyx Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Onyx Pharmaceuticals, Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Onyx Pharmaceuticals, Inc.'s pipeline products Reasons to buy - Evaluate Onyx Pharmaceuticals, Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Onyx Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Onyx Pharmaceuticals, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Onyx Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Onyx Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Onyx Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Onyx Pharmaceuticals, Inc. Snapshot 5 Onyx Pharmaceuticals, Inc. Overview 5 Key Information 5 Key Facts 5 Onyx Pharmaceuticals, Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Onyx Pharmaceuticals, Inc. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Partnered Products 11 Partnered Products/Combination Treatment Modalities 12 Pipeline Products - Out-Licensed Products 13 Out-Licensed Products/Combination Treatment Modalities 14 Onyx Pharmaceuticals, Inc. - Pipeline Products Glance 15 Onyx Pharmaceuticals, Inc. - Late Stage Pipeline Products 15 Phase III Products/Combination Treatment Modalities 15 Onyx Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 16 Phase II Products/Combination Treatment Modalities 16 Phase I Products/Combination Treatment Modalities 17 Onyx Pharmaceuticals, Inc. - Early Stage Pipeline Products 18 Preclinical Products/Combination Treatment Modalities 18 Discovery Products/Combination Treatment Modalities 19 Onyx Pharmaceuticals, Inc. - Drug Profiles 20 carfilzomib 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 oprozomib 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 ONX-0914 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 PR-924 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Onyx Pharmaceuticals, Inc. - Pipeline Analysis 29 Onyx Pharmaceuticals, Inc. - Pipeline Products by Target 29 Onyx Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 30 Onyx Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 31 Onyx Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 32 Onyx Pharmaceuticals, Inc. - Recent Pipeline Updates 33 Onyx Pharmaceuticals, Inc. - Dormant Projects 41 Onyx Pharmaceuticals, Inc. - Locations And Subsidiaries 42 Head Office 42 Other Locations & Subsidiaries 42 Appendix 43 Methodology 43 Coverage 43 Secondary Research 43 Primary Research 43 Expert Panel Validation 43 Contact Us 44 Disclaimer 44
List of Tables Onyx Pharmaceuticals, Inc., Key Information 5 Onyx Pharmaceuticals, Inc., Key Facts 5 Onyx Pharmaceuticals, Inc. - Pipeline by Indication, 2014 7 Onyx Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 9 Onyx Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 10 Onyx Pharmaceuticals, Inc. - Partnered Products in Pipeline, 2014 11 Onyx Pharmaceuticals, Inc. - Partnered Products/ Combination Treatment Modalities, 2014 12 Onyx Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2014 13 Onyx Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2014 14 Onyx Pharmaceuticals, Inc. - Phase III, 2014 15 Onyx Pharmaceuticals, Inc. - Phase II, 2014 16 Onyx Pharmaceuticals, Inc. - Phase I, 2014 17 Onyx Pharmaceuticals, Inc. - Preclinical, 2014 18 Onyx Pharmaceuticals, Inc. - Discovery, 2014 19 Onyx Pharmaceuticals, Inc. - Pipeline by Target, 2014 29 Onyx Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 30 Onyx Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 31 Onyx Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 32 Onyx Pharmaceuticals, Inc. - Recent Pipeline Updates, 2014 33 Onyx Pharmaceuticals, Inc. - Dormant Developmental Projects,2014 41 Onyx Pharmaceuticals, Inc., Subsidiaries 42
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.